Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
MLO: Medical Laboratory Observer
|
January 11, 1984
Media quality control: an unnecessary evil
P C Harris, L B Sealey, B Pitman
Journal of Hand Surgery (Edinburgh, Scotland)
|
August 7, 2002
Hand exsanguination: prospective randomised blind study of an established versus a modified technique
P C Harris, S Scott, R A Evans
Kidney International
|
May 31, 2001
Treatment prospects for autosomal-dominant polycystic kidney disease
Q Qian, P C Harris, V E Torres
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1981
Mechanisms of lymphocyte-mediated cytotoxicity. II. biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro
C F Ware, P C Harris, G A Granger
Human Molecular Genetics
|
August 1, 1993
Allelic diversity at minisatellite MS205 (D16S309): evidence for polarized variability
J A Armour, P C Harris, A J Jeffreys
The American Journal of Cardiology
|
May 15, 1983
Effect of elevating the wrist on the radial pulse in aortic regurgitation: Corrigan revisited
C A Warnes, P C Harris, H W Fritts
Human Molecular Genetics
|
January 1, 1995
Autosomal dominant polycystic kidney disease: molecular analysis
P C Harris, C J Ward, B Peral, et al.
Journal of the American Society of Nephrology : JASN
|
October 1, 1995
Polycystic kidney disease. 1: Identification and analysis of the primary defect
P C Harris, C J Ward, B Peral, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1981
The human LT serum. X. The initial form released by T-enriched lymphocytes is 150,000 m.w., associated with small nonlytic components, and can dissociate into the smaller alpha, beta, and gamma m.w. classes
P C Harris, R S Yamamoto, J Crane, et al.
Nature Medicine
|
June 1, 1995
The PKD1 gene product
P C Harris, G Germino, K Klinger, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
MLO: Medical Laboratory Observer
|
January 11, 1984
Media quality control: an unnecessary evil
P C Harris, L B Sealey, B Pitman
Journal of Hand Surgery (Edinburgh, Scotland)
|
August 7, 2002
Hand exsanguination: prospective randomised blind study of an established versus a modified technique
P C Harris, S Scott, R A Evans
Kidney International
|
May 31, 2001
Treatment prospects for autosomal-dominant polycystic kidney disease
Q Qian, P C Harris, V E Torres
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1981
Mechanisms of lymphocyte-mediated cytotoxicity. II. biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro
C F Ware, P C Harris, G A Granger
Human Molecular Genetics
|
August 1, 1993
Allelic diversity at minisatellite MS205 (D16S309): evidence for polarized variability
J A Armour, P C Harris, A J Jeffreys
The American Journal of Cardiology
|
May 15, 1983
Effect of elevating the wrist on the radial pulse in aortic regurgitation: Corrigan revisited
C A Warnes, P C Harris, H W Fritts
Human Molecular Genetics
|
January 1, 1995
Autosomal dominant polycystic kidney disease: molecular analysis
P C Harris, C J Ward, B Peral, et al.
Journal of the American Society of Nephrology : JASN
|
October 1, 1995
Polycystic kidney disease. 1: Identification and analysis of the primary defect
P C Harris, C J Ward, B Peral, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1981
The human LT serum. X. The initial form released by T-enriched lymphocytes is 150,000 m.w., associated with small nonlytic components, and can dissociate into the smaller alpha, beta, and gamma m.w. classes
P C Harris, R S Yamamoto, J Crane, et al.
Nature Medicine
|
June 1, 1995
The PKD1 gene product
P C Harris, G Germino, K Klinger, et al.
Page
of 9